The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: OGSG1203 (HERBIS-5).
 
Kazuhiro Nishikawa
Honoraria - Ajinomoto; Chugai Pharma
Research Funding - Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Daisuke Sakai
No Relationships to Disclose
 
Junji Kawada
No Relationships to Disclose
 
Ryohei Kawabata
No Relationships to Disclose
 
Tomono Kawase
No Relationships to Disclose
 
Yoshio Oka
No Relationships to Disclose
 
Naotoshi Sugimoto
No Relationships to Disclose
 
Takeshi Shimizu
No Relationships to Disclose
 
Junichi Nishijima
No Relationships to Disclose
 
Hiroko Hasegawa
No Relationships to Disclose
 
Shunji Endo
No Relationships to Disclose
 
Yutaka Isozaki
No Relationships to Disclose
 
Yutaka Kimura
No Relationships to Disclose
 
Jin Matsuyama
No Relationships to Disclose
 
Yukinori Kurokawa
No Relationships to Disclose
 
Toshio Shimokawa
No Relationships to Disclose
 
Kazumasa Fujitani
No Relationships to Disclose
 
Taroh Satoh
No Relationships to Disclose